neuroConn GmbH

neuroConn GmbH is a leading developer of high-precision technologies for neuroscientific research and sustainable therapies for mental and neurological disorders. As a subsidiary of neurocare group AG, we cover the areas of non-invasive electrical brain stimulation (tDCS, tACS, tRNS), neurofeedback and QEEG. Our goal is to enable better diagnoses and well-tolerated therapy procedures through high-quality, multifunctional devices.

With the integration of cutting-edge technologies, neurocare and our partners are dedicated to enhancing the effectiveness of non-invasive brain stimulation techniques. We focus on advancements in neuronavigation, precise target engagement, closed-loop systems, and interference stimulation methods. These innovations aim to improve the outcomes and impact of NIBS.

This year, neuroConn GmbH is celebrating its 25th anniversary.